Biotechnology (635) | Mergers & Acquisitions (635)

Browse by Subcategory

Browse by Company

AbbVie Inc. (4 contracts)
ABEONA THERAPEUTICS INC. (4)
ACCELERON PHARMA INC (1)
ACHIEVE LIFE SCIENCES, INC. (3)
Acorda Therapeutics (3)
Adamas Pharmaceuticals Inc (1)
Adaptimmune Therapeutics PLC (2)
Adhera Therapeutics, Inc. (2)
ADMA BIOLOGICS, INC. (1)
ADURO BIOTECH, INC. (2)
Advaxis, Inc. (2)
AgeX Therapeutics, Inc. (1)
Aimmune Therapeutics, Inc. (1)
AKCEA THERAPEUTICS, INC. (1)
Akebia Therapeutics, Inc. (2)
Akouos, Inc. (1)
ALBIREO PHARMA, INC. (1)
Aldeyra Therapeutics, Inc. (1)
Alexion Pharmaceuticals (9)
Alkermes plc. (1)
Allarity Therapeutics, Inc. (1)
Alliqua BioMedical, Inc. (9)
Alpha Healthcare Acquisition Corp. (1)
ALPINE IMMUNE SCIENCES, INC. (1)
Altimmune, Inc. (4)
Amgen Inc. (8)
AMICUS THERAPEUTICS, INC. (5)
AmpliPhi Biosciences Corp (3)
Anchiano Therapeutics Ltd. (1)
Anika Therapeutics (2)
APPLIED GENETIC TECHNOLOGIES CORP (1)
Aprea Therapeutics, Inc. (1)
AQUINOX PHARMACEUTICALS, INC (1)
Aravive, Inc. (1)
ARCA biopharma, Inc. (5)
ARENA PHARMACEUTICALS INC (1)
Aridis Pharmaceuticals, Inc. (1)
ARROWHEAD PHARMACEUTICALS, INC. (3)
Arsanis, Inc. (3)
ARYA Sciences Acquisition Corp II (1)
ASSEMBLY BIOSCIENCES, INC. (1)
Athenex, Inc. (2)
ATOSSA GENETICS INC (1)
AVEO PHARMACEUTICALS INC (1)
Avid Bioservices, Inc. (1)
Ayala Pharmaceuticals, Inc. (1)
AzurRx BioPharma, Inc. (1)
Beam Therapeutics Inc. (1)
BeiGene, Ltd. (1)
Big Cypress Acquisition Corp. (1)
BIO-PATH HOLDINGS INC (2)
BioCardia, Inc. (4)
BIOCRYST PHARMACEUTICALS INC (1)
Biogen Inc. (2)
Biohaven Pharmaceutical Holding Co Ltd. (3)
BioRestorative Therapies, Inc. (2)
BIOSPECIFICS TECHNOLOGIES CORP (1)
BIOTIME INC (2)
BIOVIE INC. (1)
BIOXYTRAN, INC (3)
Bison Capital Acquisition Corp. (4)
Blueprint Medicines Corp (1)
Bone Biologics Corp (2)
BridgeBio Pharma, Inc. (2)
CALADRIUS BIOSCIENCES, INC. (5)
Calyxt, Inc. (2)
CANCER GENETICS, INC (4)
CAPRICOR THERAPEUTICS, INC. (4)
CAPSTAR SPECIAL PURPOSE ACQUISITION CORP. (2)
Capstone Therapeutics Corp. (2)
CareDx, Inc. (1)
CASI Pharmaceuticals, Inc. (3)
CASTLE BIOSCIENCES INC (2)
CATABASIS PHARMACEUTICALS INC (1)
CATALYST BIOSCIENCES, INC. (3)
CATALYST PHARMACEUTICALS, INC. (1)
Celldex Therapeutics, Inc. (1)
Cellectar Biosciences, Inc. (1)
Cellular Biomedicine Group, Inc. (5)
Centessa Pharmaceuticals Ltd (1)
Chanticleer Holdings, Inc. (4)
Chardan Healthcare Acquisition 2 Corp. (2)
Chardan Healthcare Acquisition Corp. (3)
Checkmate Pharmaceuticals, Inc. (1)
ChemoCentryx, Inc. (1)
CHIMERIX INC (1)
CLEVELAND BIOLABS INC (1)
CM Life Sciences III Inc. (2)
Coherus BioSciences, Inc. (1)
Comera Life Sciences Holdings, Inc. (1)
Conatus Pharmaceuticals Inc. (1)
CONCERT PHARMACEUTICALS, INC. (1)
Constellation Alpha Capital Corp. (1)
CONSTELLATION PHARMACEUTICALS INC (1)
Corbus Pharmaceuticals Holdings, Inc. (1)
Cortexyme, Inc. (1)
CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (2)
CRISPR Therapeutics AG (1)
CTD HOLDINGS INC (1)
CTI BIOPHARMA CORP (2)
Cullinan Oncology, LLC (1)
Cybrdi, Inc. (1)
CytoDyn Inc. (1)
CYTORI THERAPEUTICS, INC. (3)
CYTRX CORP (1)
Deciphera Pharmaceuticals, Inc. (2)
DelMar Pharmaceuticals, Inc. (1)
Dermira, Inc. (1)
Dicerna Pharmaceuticals Inc (1)
Diffusion Pharmaceuticals Inc. (6)
Digital Development Partners, Inc. (2)
Dynamics Special Purpose Corp. (2)
Edge Therapeutics, Inc. (4)
Eidos Therapeutics, Inc. (1)
Eiger BioPharmaceuticals, Inc. (4)
Eliem Therapeutics, Inc. (1)
Emerald Bioscience, Inc. (1)
Emergent BioSolutions Inc. (2)
Entasis Therapeutics Holdings Inc. (1)
Environmental Impact Acquisition Corp (2)
Epizyme, Inc. (1)
Equillium, Inc. (2)
Erasca, Inc. (1)
EVOLUTIONARY GENOMICS, INC. (2)
EXACT SCIENCES CORP (4)
Exelixis (1)
EXICURE, INC. (2)
Fibrocell Science, Inc. (1)
FIVE PRIME THERAPEUTICS INC (1)
Flex Pharma, Inc. (3)
Flexion Therapeutics Inc (1)
FLUOROPHARMA MEDICAL, INC. (2)
Forma Therapeutics Holdings, Inc., (1)
Fortress Biotech, Inc. (3)
Forty Seven, Inc. (1)
FS Development Corp. (2)
FS Development Corp. II (2)
Gemphire Therapeutics Inc. (2)
Gene Biotherapeutics, Inc. (2)
GeoVax Labs, Inc. (2)
Gilead Sciences (11)
Global Blood Therapeutics, Inc. (1)
Gritstone Oncology, Inc. (2)
GT Biopharma, Inc. (2)
GTX INC (2)
GX Acquisition Corp. (2)
HALOZYME THERAPEUTICS INC (1)
HEAT BIOLOGICS, INC. (1)
HedgePath Pharmaceuticals, Inc. (1)
HilleVax, Inc. (1)
HISTOGENICS CORP (2)
HST Global, Inc. (1)
IDERA PHARMACEUTICALS, INC. (3)
Imago BioSciences, Inc. (1)
IMMUNE PHARMACEUTICALS INC (5)
ImmunoCellular Therapeutics, Ltd. (4)
IMMUNOMEDICS INC (1)
Incyte (2)
InMed Pharmaceuticals Inc. (4)
INOVIO PHARMACEUTICALS, INC. (1)
INSMED Inc (1)
Inspyr Therapeutics, Inc. (1)
Intec Pharma Ltd. (2)
INTREXON CORP (2)
Invitae Corp (11)
IONIS PHARMACEUTICALS INC (1)
IOVANCE BIOTHERAPEUTICS, INC. (1)
Isoray, Inc. (4)
Jounce Therapeutics, Inc. (1)
Kadmon Holdings, Inc. (1)
KBL MERGER CORP. IV (4)
Kindred Biosciences, Inc. (2)
Kiromic Biopharma, Inc. (1)
KIWA BIO-TECH PRODUCTS GROUP CORP (1)
Kura Oncology, Inc. (2)
LA JOLLA PHARMACEUTICAL CO (7)
LEAP THERAPEUTICS, INC. (1)
Leisure Acquisition Corp. (2)
LifeSci Acquisition Corp. (2)
Ligand Pharmaceuticals Incorporated (16)
LogicBio Therapeutics, Inc. (1)
MADRIGAL PHARMACEUTICALS, INC. (1)
Magenta Therapeutics, Inc. (1)
MANHATTAN SCIENTIFICS INC (1)
MATEON THERAPEUTICS INC (5)
Matinas BioPharma Holdings, Inc. (2)
MEDICINOVA INC (2)
Medovex Corp. (2)
MEI Pharma, Inc. (1)
MeiraGTx Holdings plc (3)
Metacrine, Inc. (1)
Millendo Therapeutics, Inc. (3)
MiMedx Group, Inc. (4)
Minerva Neurosciences, Inc. (1)
MIRAGEN THERAPEUTICS, INC. (2)
Molecular Templates, Inc. (1)
Moleculin Biotech, Inc. (1)
Momenta Pharmaceuticals, Inc. (1)
Myovant Sciences Ltd. (1)
Myriad Genetics, Inc. (3)
NantKwest, Inc. (4)
NEUROBIOLOGICAL TECHNOLOGIES INC (1)
Neurotrope, Inc. (6)
NEWLINK GENETICS CORP (2)
NOVAVAX INC (3)
NTN BUZZTIME INC (1)
NUTRA PHARMA CORP (1)
Ohr Pharmaceutical Inc (4)
Olivia Ventures, Inc. (1)
OncBioMune Pharmaceuticals, Inc (2)
OncoCyte Corp (4)
OPGEN INC (1)
Ophthotech Corp. (1)
Opko Health, Inc. (5)
Organicell Regenerative Medicine, Inc. (1)
Organogenesis Holdings Inc. (13)
ORGANOVO HOLDINGS, INC. (6)
Orgenesis Inc. (5)
Oyster Point Pharma, Inc. (1)
Pfenex Inc. (2)
PLURISTEM THERAPEUTICS INC (1)
POLARITYTE, INC. (2)
PORTOLA PHARMACEUTICALS INC (1)
Poseida Therapeutics, Inc. (2)
Prevail Therapeutics Inc. (1)
Principia Biopharma Inc. (1)
Progenics Pharmaceuticals, Inc. (3)
Prometheus Biosciences, Inc. (1)
Protagenic Therapeutics, Inc. (5)
Protalix BioTherapeutics, Inc. (1)
PROTEON THERAPEUTICS INC (2)
PROTEOSTASIS THERAPEUTICS, INC. (4)
PTC THERAPEUTICS, INC. (1)
PUMA BIOTECHNOLOGY, INC. (1)
Radius Health, Inc. (2)
Rasna Therapeutics Inc. (2)
REGENERX BIOPHARMACEUTICALS INC (1)
REGENXBIO Inc. (1)
Relay Therapeutics, Inc. (1)
Retrophin, Inc. (1)
Revolution Medicines, Inc. (1)
REXAHN PHARMACEUTICALS, INC. (3)
Rezolute, Inc. (1)
RITTER PHARMACEUTICALS INC (1)
ROCKET PHARMACEUTICALS, INC. (2)
Sana Biotechnology, Inc. (4)
SANGAMO THERAPEUTICS, INC (1)
Sarepta Therapeutics, Inc. (1)
Savara Inc (3)
SEATTLE GENETICS INC (2)
SELLAS Life Sciences Group, Inc. (2)
Sesen Bio, Inc. (1)
Sierra Oncology, Inc. (1)
Silverback Therapeutics, Inc. (3)
SOLENO THERAPEUTICS INC (2)
Solid Biosciences Inc. (5)
Sorrento Therapeutics, Inc. (12)
Spectrum Pharmaceuticals, Inc. (4)
SPHERIX INC (5)
Spinning Eagle Acquisition Corp. (4)
Spring Bank Pharmaceuticals, Inc. (3)
Sun BioPharma, Inc. (4)
SUNESIS PHARMACEUTICALS INC (1)
SYNLOGIC, INC. (4)
Synthetic Biologics, Inc. (1)
Syros Pharmaceuticals, Inc. (1)
TCR2 THERAPEUTICS INC. (1)
TENAX THERAPEUTICS, INC. (1)
TG THERAPEUTICS, INC. (5)
Tocagen Inc (1)
Translate Bio, Inc. (1)
Turning Point Therapeutics, Inc. (1)
TYME TECHNOLOGIES, INC. (1)
Ultragenyx Pharmaceutical Inc. (1)
United Therapeutics Corp (1)
Unum Therapeutics Inc. (1)
Vaccitech plc (3)
Vaxart, Inc. (5)
VERACYTE, INC. (2)
Vertex Pharmaceuticals Inc (2)
VICAL INC (2)
Viela Bio, Inc. (1)
Vir Biotechnology, Inc. (1)
VistaGen Therapeutics, Inc. (2)
VITRO DIAGNOSTICS INC (1)
vTv Therapeutics Inc. (2)
WINDTREE THERAPEUTICS INC (1)
ZAFGEN, INC. (2)
ZIOPHARM ONCOLOGY INC (1)

Recent Contracts

Agreement and Plan of Merger, dated as of May 29, 2023, by and among Greenlight Biosciences Holdings, PBC, SW ParentCo, Inc. and SW MergerCo, Inc (Environmental Impact Acquisition Corp, Filed With SEC on May 30, 2023)
Agreement and Plan of Merger, dated as of May 23, 2023, by and among IMAC Holdings, Inc., IMAC Merger Sub, LLC and Theralink Technologies, Inc (OncBioMune Pharmaceuticals, Inc, Filed With SEC on May 26, 2023)
Agreement and Plan of Merger, dated May 10, 2023, among CTI BioPharma Corp., Swedish Orphan Biovitrum AB (publ) and Cleopatra Acquisition Corp (CTI BIOPHARMA CORP, Filed With SEC on May 10, 2023)
Agreement and Plan of Merger, dated as of May 2, 2023, by and among Magenta Therapeutics, Inc., Dio Merger Sub, Inc. and Dianthus Therapeutics, Inc (Magenta Therapeutics, Inc., Filed With SEC on May 3, 2023)
Agreement and Plan of Merger, dated as of April 28, 2023, by and among Astellas US Holding, Inc., Berry Merger Sub, Inc., IVERIC bio, Inc. and, solely as provided by Section... (Ophthotech Corp., Filed With SEC on May 1, 2023)
Merger Agreement, dated as of April 24, 2023, by and among Spectrum Pharmaceuticals, Inc., Assertio Holdings Inc. and Spade Merger Sub 1, Inc. (Form of CVR Agreement included as... (Spectrum Pharmaceuticals, Inc., Filed With SEC on April 25, 2023)
Agreement and Plan of Merger, dated as of April 15, 2023, by and among Prometheus Biosciences, Inc., Merck & Co., Inc., and Splash Merger Sub, Inc (Prometheus Biosciences, Inc., Filed With SEC on April 17, 2023)
First Amendment to Agreement and Plan of Merger, dated as of April 14, 2023, by and among Calyxt, Inc. and Cibus Global, LLC (Calyxt, Inc., Filed With SEC on April 14, 2023)
Amendment No. 1 to the Agreement and Plan of Merger, dated as of April 5, 2023, by and among Adaptimmune Therapeutics plc, CM Merger Sub, Inc. and TCR (Adaptimmune Therapeutics PLC, Filed With SEC on April 5, 2023)
Agreement and Plan of Merger, dated as of March 30, 2023, by and among Diffusion Pharmaceuticals Inc., EIP Pharma, Inc. and Dawn Merger Sub Inc (Diffusion Pharmaceuticals Inc., Filed With SEC on March 30, 2023)
Agreement and Plan of Merger between the Company, Concentra and Merger Sub, dated March 26, 2023 (Jounce Therapeutics, Inc., Filed With SEC on March 27, 2023)
Agreement and Plan of Merger, dated March 12, 2023, by and among Seagen Inc., Pfizer Inc. and Aris Merger Sub, Inc (SEATTLE GENETICS INC, Filed With SEC on March 13, 2023)
Agreement and Plan of Merger, dated as of March 5, 2023, by and among Adaptimmune, CM Merger Sub, Inc. and TCR2 (Adaptimmune Therapeutics PLC, Filed With SEC on March 6, 2023)
Agreement and Plan of Merger, dated as of March 5, 2023, by and among TCR2 Therapeutics Inc., Adaptimmune Therapeutics plc and CM Merger Sub, Inc (TCR2 THERAPEUTICS INC., Filed With SEC on March 6, 2023)
Agreement and Plan of Merger, by and among the Company, Merger Sub, and Infinity, dated as of February 22, 2023 (MEI Pharma, Inc., Filed With SEC on February 23, 2023)
Second Amendment to Agreement and Plan of Merger and Reorganization, dated as of February 13, 2023, by and among Sesen Bio, Inc., Seahawk Merger Sub, Inc., and CARISMA... (Sesen Bio, Inc., Filed With SEC on February 14, 2023)
Amendment No. 1 to Amended and Restated Agreement and Plan of Merger dated February 8, 2023, by and between Oncocyte Corporation and David MacKenzie, solely in his capacity as... (OncoCyte Corp, Filed With SEC on February 13, 2023)
Agreement and Plan of Merger, dated January 31, 2023 by and between CASI Pharmaceuticals, Inc. and CASI Pharmaceuticals Holdings, Inc (CASI Pharmaceuticals, Inc., Filed With SEC on January 31, 2023)
Agreement and Plan of Merger, dated January 17, 2023, by and among Leap Therapeutics, Inc., Fire Merger Sub, Inc., Flame Biosciences LLC, Flame Biosciences, Inc., and the... (LEAP THERAPEUTICS, INC., Filed With SEC on January 23, 2023)
Agreement and Plan of Merger, dated as of January 19, 2023, by and among Sun Pharmaceutical Industries Ltd., Foliage Merger Sub, Inc. and Concert Pharmaceuticals, Inc (CONCERT PHARMACEUTICALS, INC., Filed With SEC on January 19, 2023)
Agreement and Plan of Merger, dated January 13, 2023, by and among Calyxt, Inc., Calypso Merger Subsidiary, LLC, Cibus Global, LLC and the other parties thereto (Calyxt, Inc., Filed With SEC on January 17, 2023)
Agreement and Plan of Merger, dated as of January 8, 2023, by and among Ipsen Biopharmaceuticals, Inc., Anemone Acquisition Corp., Albireo Pharma, Inc. and, solely for the limited... (ALBIREO PHARMA, INC., Filed With SEC on January 9, 2023)
Plan of Merger (BioRestorative Therapies, Inc., Filed With SEC on January 5, 2023)
Agreement and Plan of Merger, by and among Vistagen Therapeutics, Inc., VTGN Merger Sub, Inc., Pherin Pharmaceuticals, Inc., and Kevin McCarthy, dated December 20, 2022 (VistaGen Therapeutics, Inc., Filed With SEC on December 21, 2022)
Amendment No. 3 to Agreement and Plan of Merger, dated December 20, 2022 (Spring Bank Pharmaceuticals, Inc., Filed With SEC on December 21, 2022)
Form of Amendment No. 1 to the Merger Agreement dated December 5, 2022 (PROTEOSTASIS THERAPEUTICS, INC., Filed With SEC on December 5, 2022)
Agreement and Plan of Merger, dated November 19, 2022, among Merck Sharp & Dohme LLC, M-Inspire Merger Sub, Inc. and Imago BioSciences, Inc (Imago BioSciences, Inc., Filed With SEC on November 21, 2022)
Amendment No. 1 to Agreement and Plan of Merger, dated November 20, 2022 (Spring Bank Pharmaceuticals, Inc., Filed With SEC on November 21, 2022)
Agreement and Plan of Merger, by and among Aceragen, Inc., Aceragen Merger Sub, Inc., Arrevus, Inc., and Carl Kraus, dated October 18, 2021 (IDERA PHARMACEUTICALS, INC., Filed With SEC on November 14, 2022)
Side Letter Agreement, by and among Idera Pharmaceuticals, Inc., Bell Merger Sub II, LLC and NovaQuest Co-Investment Fund XV, L.P., dated September 28, 2022 (IDERA PHARMACEUTICALS, INC., Filed With SEC on November 14, 2022)
Agreement and Plan of Merger and Reorganization, dated as of July 21, 2022, by and among Silverback Therapeutics, Inc., Sabre Merger Sub, Inc. and ARS Pharmaceuticals, Inc., as... (Silverback Therapeutics, Inc., Filed With SEC on November 8, 2022)
Agreement and Plan of Merger, dated as of November 7, 2022, by and among Viatris Inc., Iris Purchaser Inc. and Oyster Point Pharma, Inc (Oyster Point Pharma, Inc., Filed With SEC on November 8, 2022)
Amended and Restated Employee Matters Agreement, dated as of August 18, 2022, by and among Ligand Pharmaceuticals Incorporated, OmniAb Operations, Inc. (f/k/a OmniAb, Inc.),... (Ligand Pharmaceuticals Incorporated, Filed With SEC on November 8, 2022)
Second Amendment to the Agreement and Plan of Merger and Reorganization, dated October 25, 2022, by and among Silverback Therapeutics, Inc., Sabre Merger Sub, Inc. and ARS... (Silverback Therapeutics, Inc., Filed With SEC on October 27, 2022)
Agreement and Plan of Merger, dated as of October 23, 2022, among Myovant Sciences Ltd., Sumitovant Biopharma Ltd., Merger Sub and, solely with respect to Article IX and Annex A,... (Myovant Sciences Ltd., Filed With SEC on October 24, 2022)
Agreement and Plan of Merger by and among the Parent, the Purchaser and the Company, dated October 23, 2022 (APPLIED GENETIC TECHNOLOGIES CORP, Filed With SEC on October 24, 2022)
First Amendment to Agreement and Plan of Merger, dated October 21, 2022, between Isoray, Inc., Isoray Acquisition Corp., Viewpoint Molecular Targeting, Inc., and Cameron Gray (Isoray, Inc., Filed With SEC on October 24, 2022)
Agreement and Plan of Merger and Reorganization, by and among the Company, Merger Sub, and Ayala, dated as of October 18, 2022 (Advaxis, Inc., Filed With SEC on October 19, 2022)
Agreement and Plan of Merger, dated as of October 18, 2022, by and among Advaxis, Inc., Doe Merger Sub, Inc., and Ayala Pharmaceuticals, Inc (Ayala Pharmaceuticals, Inc., Filed With SEC on October 19, 2022)
Agreement and Plan of Merger, dated as of October 17, 2022, by and among Akouos, Inc., Eli Lilly and Company and Kearny Acquisition Corporation (Akouos, Inc., Filed With SEC on October 18, 2022)